Founded in 2009, 4A Biotech Co., Ltd. is a high-tech enterprise integrating research, development, production, sales and technical services of biological reagents. With a long-standing background of industry cooperation, the company has hired a team of domestic and foreign experts to establish a variety of technology platforms, including molecular biology, cell biology, immunology, hematology and other fields, with various types of immunity represented by streaming technology. In addition to the comprehensive sales network in the country, the company has also established sales channels in North America, Europe and other places. The products are sold overseas and highly recognized by the market.
The company's main business includes three major sections of experimental reagent products, technical services and in vitro diagnostic reagents in the field of biomedicine. Products and technologies cover single / polyclonal antibody preparation, purification and labeling, kit development and application, cytokines and flow-through antibodies, providing a number of professional one-stop services for hospitals, universities, enterprises and institutions. Excellent brand reputation and popularity.
The company has established a production line for in vitro diagnostic reagents in line with GMP standards. It has successfully pushed a diagnostic product to the clinical trial stage. In the next three years, the company will focus on the diagnosis of malignant diseases such as leukemia and lymphoma, and concentrate on reporting dozens of autonomy. In vitro diagnostic reagent products are developed by continuously transforming the company's core technology from scientific research to clinical application, and plays an active role in promoting clinical immunology, diagnosis of blood system diseases, tumor screening, and post-treatment immune monitoring.
Sizhengbo Bio has always adhered to the development philosophy of “ Mastering the source technology, serving life science, being a leader in the localization of high-end reagents, and becoming a strong competitor in the international market ” , standardizing enterprise operations, strict quality management, and building coverage of R&D, production and market. The corporate vision is to develop into one of the most competitive high-tech enterprises in the field of life science and clinical diagnosis.